| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2827 | Jmx0207 | Novel inhibitor of viral protease function, suppressing Zika virus Infection both In vitro and In vivo |
|
| DCC2828 | Jmx0254 | Novel Potent NS4B Inhibitor for the Treatment of Dengue Virus Infection |
|
| DCC2829 | Jmx0510-2 | Novel Potent Human Adenovirus Inhibitor, showing improved anti-HAdV activity (IC50 = 0.27 μM), significantly decreasing cytotoxicity (CC50 = 156.8 μM), and lowering in vivo toxicity (maximum tolerated dose = 150 mg/kg in hamster) as compared with niclosam |
|
| DCC2830 | Jnj-1013 | Novel potent and selective IRAK1 degrader, effectively degraded cellular IRAK1 protein with a DC50 of 3 nM in HBL-1 cells |
|
| DCC2831 | Jnj-10311795 | Novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase |
|
| DCC2832 | Jnj-17029259 | Vascular endothelial growth factor receptor-2 (VEGF-2) kinase inhibitor |
|
| DCC2833 | Jnj-17148066 | Estrogen receptor ESR1 agonist |
|
| DCC2834 | Jnj-1930942 | Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor |
|
| DCC2835 | Jnj-20788560 | Selective delta opioid receptor agonist as a potent and efficacious antihyperalgesic agent |
|
| DCC2836 | Jnj-26076713 | Novel EthR inhibitor, boosting antituberculous activity of ethionamide |
|
| DCC2837 | Jnj-28330835 | Selective androgen receptor modulator with minimal prostate hypertrophic activity stimulating sexual behavior in female rats |
|
| DCC2838 | Jnj-28583867 | Histamine H3 receptor antagonist and serotonin reuptake inhibitor |
|
| DCC2839 | Jnj-40068782 | Novel potent, selective, and systemically active positive allosteric modulator (PAM) of mGlu2-receptors |
|
| DCC2840 | Jnj-40255293 | Novel Adenosine A 2A /A 1 Antagonist With Efficacy In Preclinical Models of Parkinson's Disease |
|
| DCC2841 | Jnj-40264796 | Negative control for JNJ-40068782 |
|
| DCC2842 | JNJ-40355003 Featured | JNJ-40355003 is a potent and selective atty acid amide hydrolase (FAAH) inhibitor. |
|
| DCC2843 | Jnj-40573663 | Negaive control for JNJ-42396302 |
|
| DCC2844 | Jnj-40929837 | Novel potent, orally active LTA4H inhibitor |
|
| DCC2845 | Jnj-42396302 | Novel inhibitor of PDE10A |
|
| DCC2846 | Jnj-42491293 | Novel ago-PAM for the metabotropic glutamate receptor subtype 2 (mGluR2) |
|
| DCC2847 | Jnj-49153390 | Novel inhibitor of respiratory syncytial virus (RSV), binding the RSV F glycoprotein and inhibiting membrane fusion |
|
| DCC2848 | Jnj-53721590 | Negative control for JNJ-54119936 |
|
| DCC2849 | Jnj-61432059 | Novel TARP γ-8 Selective AMPAR Negative Modulator |
|
| DCC2850 | Jnj-dgat1-a | Selective DGAT1 inhibitor |
|
| DCC2851 | Jnj-dgat2-b | Selective DGAT2 inhibitor |
|
| DCC2852 | Jns 1-40 | Novel cysteine-reactive covalent ligand, selectively targeting C377 of PPP2R1A to impair breast cancer signaling, proliferation, and in vivo tumor growth |
|
| DCC2853 | Jp1201 | Novel SMAC mimetic, sensitizing non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner |
|
| DCC2854 | Jp4-039 | Non-toxic radioprotector GS-nitroxide, improving hematopoiesis in long-term bone marrow cultures (LTBMCs) |
|
| DCC2855 | Jr-220 | Non-toxic anti-relapse agent, acamprosate |
|
| DCC2856 | Jra-003 | Novel selective inhibitor of nuclear translocation of IKKα as the most potent synthetic gibberellin against cancer-derived cell lines, displaying no cytotoxicity in cells derived from noncancerous sources (HEK 293T, HS 578BST, HS 888Lu, HS 895Sk, HUVEC) |
|
